SHANGHAI, June 28, 2020 /PRNewswire/ -- Chinese insulin manufacturer Gan & Lee Pharmaceuticals (SHSE: 603087), Qiming's portfolio company today lands on the A-shares main board market. The issue price of Gan & Lee is RMB 63.32 per share. The stock opens at RMB 91.18 per share, up 44%,...
from PR Newswire: https://ift.tt/2ZjDFC5
No comments:
Post a Comment